Vimarsana
Biggest News Aggregation in the World

Page 9 - Universal Registration Document News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Universal Registration Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Universal Registration Document Today - Breaking & Trending Today

Societe Generale : First amendment to the Universal Registration Document filed on 3 May 2024 under number D-24-0094-A01 - Vimarsana News

Societe Generale : First amendment to the Universal Registration Document filed on 3 May 2024 under number D-24-0094-A01

A French corporation with share capital of 1,003,724,927.50 euros Registered office: 29 boulevard Haussmann - 75009 PARIS 552 120 222 R.C.S. PARIS ...

Societe Generale : 1st amendment to 2024 Universal Registration Document - Vimarsana News

Societe Generale : 1st amendment to 2024 Universal Registration Document

A French corporation with share capital of 1,003,724,927.50 euros Registered office: 29 boulevard Haussmann - 75009 PARIS 552 120 222 R.C.S. PARIS ...

CLARIANE: Renewal of the Revolving Credit Facility and Update on the Refinancing Plan - Vimarsana News

CLARIANE: Renewal of the Revolving Credit Facility and Update on the Refinancing Plan

Regulatory News: Clariane announced today that it has renewed the drawdown of its RCF for a period of 6 months for an amount of €492.5 million, in accordance with the terms of the contract...

Ipsen appoints Keira Driansky as EVP, President of North America - Vimarsana News

Ipsen appoints Keira Driansky as EVP, President of North America

PARIS, FRANCE, 2 May 2024 - Ipsen , a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024....

ABIONYX Pharma: Availability of the Universal Registration Document for the Year 2023 - Vimarsana News

ABIONYX Pharma: Availability of the Universal Registration Document for the Year 2023

Regulatory News: ABIONYX Pharma , a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s only natural recombinant apoA-I,...